A Curated Reference for Innovators
A map of the standards bodies, regulators, and ethics initiatives that shape real-world neurotechnology deployment.
New neurotechnology products launch globally each year. Most are not inventing governance from scratch: they inherit decades of medical device, software, and data accountability frameworks. This reference helps teams find those frameworks early, reduce redesign, and move faster with credible evidence and durable procedures.
Last reviewed: February 2026. Suggestions welcome.
A Practical Starting Point for Neurotech Innovators
This index points to primary sources that govern safety, performance, quality management, cybersecurity, evidence expectations, and emerging ethics frameworks in neurotechnology. It is designed to help teams align early and avoid preventable redesign and commercialization delays.
This is a living resource, and we warmly welcome suggestions for additional organizations to include.
On this website, you will find:
Major International Standard Bodies
Technical organizations defining safety, interoperability, and device standards.
Regulatory and harmonization bodies
Agencies setting approval pathways and aligning global medical-device rules.
Learnings from Success in Other fields
Lessons from cybersecurity and cardiology for secure, robust neurotech.
Ethical Recommendations and Efforts in Progress
Groups shaping emerging ethical and human-rights frameworks for neurotechnology.
Regulation
Current governmental actions to protect neural data and mental privacy.
Technical Standards and Regulatory Organizations for Neurotechnology
The neurotechnology ecosystem is supported by a network of international standards bodies and regulatory authorities that shape how safety, interoperability, and ethics are defined. Together, these organizations ensure neurodevices meet consistent technical, clinical, and ethical benchmarks worldwide.
Some Major International Standards Bodies
Develops global safety, biocompatibility, and risk-management standards for implantable neural devices and medical systems (e.g., ISO 14708 and 10993 series). Its new subcommittee (JTC 1/SC 43) is creating foundational frameworks for brain–computer interfaces (BCIs).
Global group developing shared definitions, data formats, and reporting guidelines for brain–computer interfaces. Works to ensure BCI systems use consistent terminology and interoperable metadata so researchers, companies, and regulators can compare results and exchange data more easily.
Sets electrical-safety and electromagnetic-compatibility requirements for medical and neural equipment through the IEC 60601 and 80601 series. Core to ensuring essential performance of stimulators, EEG systems, and neuroimaging devices.
U.S.-based body harmonizing ISO/IEC standards and producing U.S.-specific adaptations (e.g., ANSI/AAMI NS4 for TENS). Serves as the primary link between global standards and FDA recognition.
Publishes engineering and data-interoperability standards for BCIs, neurofeedback systems, and connected medical devices. Current efforts (e.g., IEEE P2731, P2794, P7700) address unified terminology, research reporting, and responsible neurotech design.
Expert consortium developing safety and reporting standards for transcranial ultrasound neuromodulation (TUS), addressing a major gap in non-invasive brain-stimulation guidance.
Creates biomedical materials and testing standards relevant to neural implants and MRI safety (e.g., ASTM F2182, F2503). Complements ISO/IEC by specifying mechanical, thermal, and biological test methods.
Regulatory and Harmonization Bodies
Coalition of global regulators including the U.S. FDA, UK MHRA, Japan's PMDA, China's NMPA, Australia's TGA, Health Canada, and the European Commission. It aligns medical device frameworks and provides guidance on software as a medical device (SaMD), post-market surveillance, and quality management systems important to neurotechnology.
Global Regulatory Authorities
Primary regulator for medical devices in the U.S., overseeing device classification, premarket pathways (510(k), De Novo, PMA), clinical trials, and post-market surveillance. It sets requirements for safety, human factors, cybersecurity, and implant performance, and plays a central role in global harmonization through IMDRF working groups on AI/ML and Software as a Medical Device.
Defines the legal framework for CE-marked neurodevices in Europe. It integrates ISO and IEC standards into conformity assessment and shapes regulation of AI, digital health, and medical devices across the EU.
Oversees medical device safety, market surveillance, and certification within the UK. It maintains alignment with the EU MDR while implementing UK-specific conformity assessment through the UKCA mark.
Evaluates and approves medical devices under Japan's Ministry of Health, Labour, and Welfare. It regulates neural implants and BCIs and contributes to international harmonization through IMDRF.
China's central medical device regulator responsible for registration, safety evaluation, and adoption of international standards for neurotechnology through its Center for Medical Device Evaluation (CMDE).
Regulates medical devices and neurotechnology systems through risk-based classification and conformity assessments. It participates actively in IMDRF and recognizes global standards.
Regional benchmark regulator providing clear classification and expedited pathways for medical devices. It aligns closely with IMDRF guidance and serves as a leading model for neurotechnology regulation in Asia-Pacific.
National health surveillance agency regulating medical devices including neurostimulation and diagnostic technologies. It uses a risk-classification system that follows IMDRF principles.
COFEPRIS (Federal Commission for the Protection against Sanitary Risk, Mexico)
Regulates approval, importation, and compliance of medical devices in Mexico. It increasingly aligns with IMDRF and Pan American Health Organization guidance.
Develops global standards for unique device identification (UDI) and automatic identification and data capture (AIDC). These standards ensure traceability, supply chain integrity, and lifecycle management for implantable and connected neural devices.
BSI (British Standards Institution)
The UK's national standards body and a notified body for medical device certification. It adopts ISO and IEC norms such as BS EN ISO 14971 and 14708 series and conducts conformity assessments for neurotechnology products entering the UK and EU markets.
One example of enforceable medical device quality governance within a globally harmonized system:
FDA Quality Management System Regulation (QMSR) — United States
The U.S. FDA’s Quality Management System Regulation (QMSR) modernizes 21 CFR Part 820 and aligns U.S. medical device requirements with ISO 13485. QMSR governs design controls, risk management, supplier oversight, corrective actions, and lifecycle documentation for all regulated medical device manufacturers.
For neurotechnology companies developing products that diagnose, treat, or prevent disease, these requirements are enforceable and audit-based. They represent one regional implementation of globally converging quality expectations across medical device markets.
Looking to Other Fields
Above are organizations working on technical neuroscience standards. Now, we will go into other fields where we can find technical standards that can apply to unique questions that neurotech innovators are met with.
Related Field: Cybersecurity & Medical Device Security → Mental Privacy
Relevant Existing Regulations and Standards
HIPAA (1996)
- National rules for privacy and security of health information.
- Applies to any medical device that collects or transmits PHI.
FDA Cybersecurity Requirements (2023)
- Cybersecurity plan required in every device submission.
- Mandatory SBOM (Software Bill of Materials).
- Emphasis on vulnerability management and lifecycle security.
ANSI/AAMI Standards
- SW96:2023 — End-to-end device cybersecurity framework.
- TIR57:2016 — Cybersecurity risk management principles.
- TIR97:2019 — Manufacturer practices for secure design and maintenance.
Why These Resources Matter for Neurotech
Neural data is uniquely sensitive because even simple recordings can reveal mood, attention, fatigue, or intent, which places neurotechnology devices in the same category as technologies that require mature security practices. Any neural device that streams data to a phone or to the cloud, whether a headset, wearable, or implant, faces the same attack surface as connected medical devices and is exposed to familiar risks such as signal interception, unauthorized access, and remote manipulation. In this context, safety and privacy are inseparable. A cybersecurity failure is not just a data breach; it can directly affect user safety or device function. Medical device frameworks already treat cybersecurity as a core safety requirement rather than a secondary concern.
For neurotechnology companies, adopting standards such as HIPAA, FDA cybersecurity guidance, and ANSI/AAMI technical frameworks provides clear and defensible baselines instead of improvised policies. As state and federal agencies begin to regulate neural data even for consumer products, early alignment with medical-grade expectations helps avoid costly adjustments later. The advantage is that the model already exists. Decades of work in cardiology, diabetes, and other device-heavy fields have produced reliable engineering practices for encrypted data pipelines, secure telemetry, and long-term monitoring, and these practices map directly onto the challenges neurotechnology is now encountering.
Related Field: Cardiology → Data Governance & Device Lifecycle
Relevant Existing Standards
Remote Monitoring Frameworks
- EHRA/HRS Expert Consensus on Remote Monitoring - Defines secure workflows for transmitting data from implanted cardiac devices to clinicians. Emphasizes encrypted telemetry, automated alerts, and structured follow-up intervals.
- Manufacturer Remote Monitoring Systems - These are the commercial platforms created by cardiac device companies to monitor their own implanted products. Medtronic CareLink, Boston Scientific Latitude, Abbott Merlin.net. Provide secure data pipelines, event detection, audit trails, and long-term patient oversight.
Device Replacement & Lead Management
- HRS Expert Consensus Statement on CIED Lead Management and Extraction (2017) - Guidelines for when to replace, extract, or abandon leads. Sets expectations for infection prevention, device retirement, and system upgrades.
Post-Market Surveillance
- FDA Post-Approval Studies Program - Monitors safety and performance of pacemakers and ICDs over years to decades.
- Industry Surveillance Registries - Large-scale datasets (e.g., the Medtronic Product Surveillance Registry) for trend analysis, reliability tracking, and recall support.
Why These Resources Matter for Neurotech
Cardiology has already solved many of the problems neural implants are now encountering: chronic implantation of electronics in sensitive tissues, secure long-term data transmission, and maintaining safe patient–device relationships over many years.
"Cardiology is a good parallel because it was one of the first places where we did remote monitoring. Medtronic and Boston Scientific had bedside modules that communicated with implanted devices so they could do proactive monitoring of adverse events. Those systems had to be very secure, and when we moved into neuromodulation, we took our cues directly from what cardiac and diabetes devices were already doing."
— Blythe Karow, medtech expert
Remote cardiac monitoring created the first large-scale model for continuous physiological data streaming. Bedside transmitters from Medtronic and Boston Scientific set expectations for encrypted telemetry, automated alerts, and dependable device–cloud communication.
Device Lifecycles
Pacemakers and ICDs demonstrate how to manage full device lifecycles – from first implant through upgrades, battery depletion, and eventual extraction – with standardized pathways for patient safety.
Post-Market Oversight
They show how to maintain post-market oversight through registries, regular follow-up intervals, and secure clinician dashboards.
Proven Roadmap
For neural implants, adopting the cardiology playbook provides an immediate, validated roadmap for high-stakes device reliability, long-term data governance, and secure patient monitoring.
Instead of improvising new frameworks, neurotech can align early with cardiology's proven standards – lowering risk, strengthening safety, and ensuring continuity for devices expected to stay in the body for decades.
Ethical Recommendations and Efforts in Progress
Just as essential as technical standards and regulation are the ethical frameworks guiding neurotechnology. Because neurotechnology touches domains that other fields cannot fully address—such as mental privacy, cognitive enhancement, neural data governance, and consent for mind-altering or mind-interfacing devices—neurotech innovators must navigate questions that are still largely unresolved. While there are principles of neuroethics that are generally agreed upon, there are currently no universal ethical standards for neurotechnology, but a number of leading organizations are actively developing recommendations, principles, and tools. Below is an overview of the groups shaping this emerging landscape and the ethical guidance underway at each.
Leading Organizations and Initiatives Shaping Neuroethics
The OECD has created the Neurotechnology Toolkit, which provides guiding values and action steps neuroentrepreneurs can take when innovating to align with ethical innovation. The OECD has also provided recommendations that includes standards startups should abide by when creating their ventures.
UNESCO has created a draft of the first Recommendation on the Ethics of Neurotechnology. This recommendation consists of shared values and principles, pinpoint ethical challenges, and proposed concrete policy actions to ensure the ethical development, deployment, and use of neurotechnology globally. UNESCO has also put out a 2023 Neurotechnology Landscape review identifying the scientific advancements and major trends and a 2021 Ethical Issues of Neurotechnology Report.
The Council of Europe, through its CDBIO committee organized a roundtable with the OECD and put out a report: Neurotechnologies and Human Rights Frameworks. The report recommends inclusive societal deliberation on how neurotechnologies should be regulated, and emphasises that governance must embed human-rights protections from design through deployment.
The Neurorights Foundation has published a report on privacy practices in consumer nanotechnology companies and well as a report on the existing gaps of human rights considerations in neurotechnology. The Neurorights Foundation has collaborated with others to create a set of recommendations for responsibly developing deploying neurotechnologies as well.
The IEEE Brain Neuroethics Subcommittee is developing a comprehensive neuroethical framework to help guide the responsible development and deployment of neurotechnologies. This framework maps the full landscape of neurotechnologies and identifies the key ethical, legal, social, and cultural implications (ELSCI) that arise across research, development, clinical use, evaluation, and adoption. Its goal is to support not only researchers and developers but also regulators, funders, clinicians, ethics boards, and end users in staying aware of these issues and actively participating in ongoing ethical discourse.
The BRAIN Initiative published a set of Neuroethics Guiding Principles (2018) that articulate key commitments: make safety paramount; anticipate issues around capacity, autonomy and agency; protect the privacy and confidentiality of neural data; attend to possible malign uses of neuroscience tools; use caution when moving tools into medical/non-medical uses; identify public concerns; encourage public education and dialogue; behave justly and share benefit
Published joint work addressing neurodata and relevant use cases, examining data-protection implications and emerging governance needs for neurotechnology.
Released the report "Foundations and Principles for the Regulation of Neurotechnologies and the Processing of Neurodata from the Perspective of the Right to Privacy" (A/HRC/58/58). Establishes the basis for a conceptual regulatory framework for neurotechnology and neurodata; Defines core principles including protection of human dignity, safeguarding mental privacy, recognition of neurodata as highly sensitive personal data, and requirements for informed consent; Emphasizes incorporation of ethical values, precautionary approaches, accountability, secure neurodata handling, non-discrimination, and robust fundamental-rights protections.
Produced "Humanistic Neurotechnology: A New Opportunity for Spain", outlining: The global state of neurotechnology R&D and its current clinical and non-clinical applications; An overview of ethical, legal, and social challenges arising from neurotechnology; Initial policy recommendations for supporting "humanistic neurotechnology" — technologies shaped by holistic human welfare and human-rights promotion.
Published "Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives," a framework identifying key neuroethical questions for scientists across seven national brain initiatives. Includes questions related to identity, agency, free will, and the nature of reasoning.
The RHC, an independent expert committee that assesses the implications of emerging technologies, published a report recommending: A proportionate regulatory framework that supports safe commercialization of medical neurotechnologies and addresses under-regulation of non-medical neurotechnologies. A forward-looking governance framework to address emerging ethical challenges in neurotechnology.
Released "Understanding the Data Flows and Privacy Risks of Brain-Computer Interfaces" (in collaboration with IBM), analyzing: How BCIs collect and process neurodata; Benefits and risks across sectors including health, gaming, employment, education, smart cities, neuromarketing, and defense; Technical and policy strategies to mitigate privacy risks.
Opinion & Action Plan on Data Protection and Privacy (Ethics & Society): Recommends data-protection measures for long-term brain data storage, governance, anonymization, and privacy-by-design.
Opinion on Responsible Dual Use: Identifies ethical challenges of neuroscience and neurotechnology in political, intelligence, security, and military contexts.; Applies Responsible Research and Innovation (RRI) principles to distinguish responsible vs. irresponsible dual-use
The Japan Neuroscience Society, Ethics and COI Committee
Published Guidelines for Ethics-Related Problems in Non-Invasive Research on Human Brain Function, offering clinical and research guidance or non invasive neuroscience tools grounded in Japanese law and ethical principles.
Produced "Towards a Governance Framework for Brain Data" through a workshop series, offering recommendations to address gaps in national and international neurotechnology governance.
Published "iHuman: Blurring Lines Between Mind and Machine," reviewing advancements in neurotechnology and providing regulatory recommendations to support innovation while protecting the public.
Developing tools for private-sector neuroethical innovation, focused on practical guidance for responsible development, deployment, and governance of neurotechnology. Tools being workshopped include a toolkit for neuroentrepreneurs, WEF Neurotrust Index, a unified privacy policy, investor ethics and reputation risk matrix, investor due diligence questions, WEF Neurotrust Index, neural data ownership and handling guidelines, and a lived experience engagement rubric. Produced by BrainMind.
Regulations
Governmental attention to neurotechnology, especially around mental privacy, neural data governance, and cognitive liberty, is accelerating. While no comprehensive global regulatory framework exists yet, U.S. states and countries around the world have been establishing protections. Below is an overview of the major legislative efforts shaping the regulatory landscape.
Chile was the first country to recognize neurorights at the constitutional level, establishing protections around mental privacy, free will, and identity in response to emerging neurotechnologies.
Several U.S. states have passed or expanded privacy laws to explicitly include neural or "inference" data. These measures bring consumer neurotechnology devices and platforms under heightened scrutiny and set early precedents for state-level regulation.
Introduced by Senators Chuck Schumer, Maria Cantwell, and Ed Markey, the MIND Act directs the Federal Trade Commission to study and issue recommendations regarding companies that collect, analyze, sell, or manipulate neural and related data capable of inferring mental states or experiences. It represents the first federal effort to define and standardize protections for neural data.
This applies broadly in the medical device landscape: all medical device manufacturers, including neurotech software as a medical device, must have robust quality management systems to commercially distribute their devices. The FDA has modernized 21 CFR Part 820, aligning U.S. medical device quality requirements with ISO 13485 under the new Quality Management System Regulation (QMSR), effective Feb 2026. This change harmonizes expectations around design controls, risk management, supplier controls, documentation, and post-market oversight.
Conclusion
This resource is designed as a practical starting point for founders, researchers, investors, and policymakers navigating safety, interoperability, and neural data governance. Neurotechnology can grow quickly and responsibly if technical rigor and ethical foresight evolve together. This is a living resource, so we welcome any suggestions for additions and resources that would make it more complete.
Contributions
This piece was produced by Audree Rumberger, Anna Riggs, and Sharena Rice.
We would like to acknowledge Diana Saville and Karen Rommelfanger for reading drafts and providing recommendations. We also thank Erika Ross Ellison, Daniel Powell, and Blythe Karow, for taking the time to share your perspectives in the space of neurotech standards.
Neurotechnology Standards & Governance